News and blogs
27 results found.
From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
What we can achieve with £1 million
We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers
Booster vaccines: How we helped make the research happen
Beating blood cancer isn't just about spending money on research, but bringing the right people together at the right time. In this blog, we explain how we helped make booster vaccine research happen and how we see ourselves as a convener of research as well as a funder.
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
Do people with myeloma have an antibody response to the Covid vaccine?
How can I get involved in blood cancer research?
In November 2020, we asked our community to complete our survey and help us set our research priorities for the next five years.
Covid vaccine: should people with blood cancer get an antibody test?
Here's what we think people with blood cancer should know about antibody tests, such as how they work and what the results might mean for you.
From coronavirus to clinic: how did we get a vaccine?
We know a lot of people with blood cancer have questions on whether the coronavirus vaccine is safe after such a short amount of time. We hope to answer some of these questions by explaining how these vaccines have been developed.
The coronavirus vaccine: what you need to know
We explain what we know about the potential vaccines and what they could mean for people with blood cancer.
How does the coronavirus affect people with blood cancer?
We're funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus. This could lead to tailored advice for people with blood cancer during this pandemic.
New research hope for those with a rare type of leukaemia
Our research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
What causes leukaemia and how can we use this information to better treat it?
How does the immune system recognise and destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells. These white blood cells are usually very good at killing cancer cells, but may be unable to kill all of the Hodgkin lymphoma cells. Bloodwise Visiting Fellow Dr Zumla Cader has been investigating why...
Beating blood cancer: how decades of research makes us excited about the future
Last week Professor Pamela Kearns, one of the UK’s leading blood cancer researchers, gave a talk at St James’s Palace about the progress we’ve made in blood cancer research, and why we believe blood cancer can be beaten in the next few decades.
How did a weapon of war become a blood cancer treatment?
As we pay tribute to the soldiers of World War I, we look at the surprising link between the battlefields of France and blood cancer research.
By the end of the programme, I didn’t feel despair. I felt hope.
War in the Blood, a new BBC documentary follows two people who received CAR-T therapy, a groundbreaking new treatment for blood cancer, as part of a clinical trial. Kate, our Senior Support Services Manager, reviews the documentary
How to cope with stress: tips from Bloodwise researchers
For Mental Health Awareness Week, two Bloodwise-funded researchers share things they do to try to maintain mental wellbeing in a stressful environment.
How a virus can lead to lymphoma
Some types of lymphoma are associated with high levels of a small piece of genetic material called microRNA-155. Professor Michelle West has been investigating how a virus that causes lymphoma increases the production of this cancer-driving microRNA.
Bloodwise research highlights 2018
It’s been a great year in blood cancer research, from CAR-T therapy to a new understanding of how leukaemia develops in children. We take a look back at some of the breakthroughs our supporters have helped to fund in 2018.